Cathie Wood's Pre-Christmas Sale: Ark Invest Dumps Even More Tesla, Palantir Stock

Comments
Loading...

A day before Christmas, on Tuesday, Cathie Wood-led Ark Invest made significant adjustments to its portfolio, notably selling shares of Tesla Inc. TSLAPalantir Technologies Inc. PLTR, and Block Inc. SQ. Notably, Ark has been shedding shares of both Palantir and Tesla this week. Palantir shares have run up a whopping 397% so far this year, while Tesla has appreciated 86% in a similar period.

Don’t Miss:

The Tesla Trade

Ark Invest executed a notable transaction by selling 18,847 shares of Tesla Inc. through its ARK Innovation ETF ARKK. This sale, valued at approximately $8.7 million based on Tesla’s closing price of $462.28, comes amid discussions surrounding Tesla’s future valuation. Elon Musk recently speculated that Tesla could surpass the value of all transport companies except SpaceX. Despite these ambitious projections, Tesla’s stock has been influenced by potential challenges, such as the possible cancellation of the $7,500 EV tax credit in the U.S., which could impact sales.

The Palantir Trade

Ark Invest also reduced its Palantir holdings, selling 42,293 shares from the ARKK fund. This transaction was valued at approximately $3.5 million, given Palantir’s closing price of $82.38. Palantir’s stock has been on a remarkable upward trajectory, reaching all-time highs. The company’s strong performance is largely attributed to its strategic positioning in the AI sector, with shares surging over 380% this year, driven by robust demand for AI solutions.

The Block Trade

In another strategic move, Ark Invest sold 23,962 shares of Block Inc. from the ARKK fund, amounting to about $2.2 million based on the closing price of $91.08. The Bitcoin BTC/USD-focused company’s recent financial performance has been mixed, with its third-quarter earnings surpassing expectations but revenues falling short.

Other Key Trades:

  • Sold 50,163 shares of Adaptive Biotechnologies Corp from ARKG.Bought 35,598 shares of CRISPR Therapeutics AG via ARKK and ARKG.
  • Bought 269,976 shares of GitLab Inc via ARKK.Bought 53,371 shares of 10X Genomics Inc for ARKK and ARKG.

Read Next: 

Looking For Higher-Yield Opportunities In A Shifting Market?

The changing interest rate environment has created an incredible opportunity for income-seeking investors to earn massive yields, but not through dividend stocks… Certain private market real estate investments are giving retail investors the opportunity to capitalize on these high-yield opportunities and Benzinga has identified some of the most attractive options for you to consider

For instance, the Ascent Income Fund from EquityMultiple targets stable income from senior commercial real estate debt positions and has a historical distribution yield of 12.1% backed by real assets. With payment priority and flexible liquidity options, the Ascent Income Fund is a cornerstone investment vehicle for income-focused investors. First-time investors with EquityMultiple can now invest in the Ascent Income Fund with a reduced minimum of just $5,000.

Benzinga Readers: Earn a 1% return boost on your first EquityMultiple investment when you sign up here (accredited investors only).

Don't miss out on this opportunity to take advantage of high-yield investments while rates are high. Check out Benzinga's favorite high-yield offerings.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!